The main causes of uterine cancer
Uterine cancer develops when cells in the uterus grow abnormally and form a tumor. The most common type, endometrial cancer, starts in the lining of the uterus called the endometrium. Most cases happen because of an imbalance in hormones—specifically too much estrogen relative to progesterone—which causes the endometrial cells to multiply faster than normal. Over time, some of these cells can become cancerous.
The second most common type, uterine sarcoma, starts in the muscle layer of the uterus itself rather than the lining. Sarcomas are rarer and develop through a different process, though the exact cause is often unclear. Both types can spread beyond the uterus if not caught early, which is why understanding what increases your risk matters.
Unlike some cancers, uterine cancer does not have a single cause. Instead, it results from a combination of factors that make cells more likely to become abnormal. Some of these factors you cannot change—like your age or family history. Others, like weight and hormone use, are things you might be able to influence.
Key Takeaways
- Most uterine cancer is endometrial cancer, caused by too much estrogen stimulating the uterine lining to grow abnormally over time.
- Age is the strongest risk factor—most cases occur in people over 50, when hormone changes naturally happen.
- Obesity increases risk because fat tissue produces estrogen, and higher estrogen levels fuel abnormal cell growth.
- Diabetes, high blood pressure, and tamoxifen use (a breast cancer treatment) all raise the risk of uterine cancer.
- Abnormal vaginal bleeding is often the first sign and should be checked by a doctor, especially after menopause.
How estrogen imbalance leads to cancer
Estrogen normally triggers the endometrium to thicken each month during the menstrual cycle. Progesterone then signals the lining to shed. When progesterone levels are too low or estrogen stays high without enough progesterone to balance it, the endometrium keeps thickening instead of shedding. This constant overgrowth creates more opportunities for cells to mutate.
Over months or years, some of these cells develop genetic changes that make them grow faster and ignore the body's normal stop signals. Eventually, a cluster of these abnormal cells forms a tumor. This is why the cancer typically develops slowly—it is the result of accumulated damage rather than a single event.
Estrogen imbalance is especially common after menopause, when the ovaries stop producing progesterone but fat tissue continues making estrogen. This is one reason why uterine cancer is much more common in older people. It is also why obesity is such a strong risk factor—more fat tissue means more estrogen production.
Age and natural hormone changes
Most uterine cancer occurs in people over 50, and the average age at diagnosis is around 63. This is not because age itself causes cancer, but because the longer you live, the more time cells have to accumulate the genetic changes that lead to cancer. Additionally, hormone shifts during and after menopause create conditions that favor abnormal endometrial growth.
Before menopause, progesterone from your ovaries helps protect the endometrium by keeping estrogen in check. After menopause, progesterone drops sharply while estrogen from fat tissue remains, tipping the balance. This hormonal shift is why postmenopausal bleeding—any vaginal bleeding after your periods have stopped—is a red flag that warrants medical evaluation.
Younger people can still develop uterine cancer, but it is uncommon. When it does occur in younger women, it is often linked to other risk factors like obesity, diabetes, or a genetic syndrome that runs in families.
Obesity and metabolic conditions
Obesity is one of the strongest modifiable risk factors for uterine cancer. People with obesity have higher circulating estrogen levels because fat cells produce the hormone. The more excess weight, the more estrogen is produced, and the greater the risk of endometrial overgrowth. Studies show that people with obesity have two to three times the risk compared to people at a healthy weight, and the risk increases further with greater weight gain.
Metabolic conditions often accompany obesity and add to the risk. Type 2 diabetes increases uterine cancer risk independently, even in people who are not overweight. High blood pressure and high cholesterol also raise the risk. These conditions often cluster together—a pattern called metabolic syndrome—and together they create a stronger hormonal environment that favors cancer development.
The good news is that these are factors where change is possible. Weight loss, managing blood sugar, and treating high blood pressure may lower risk, though research on whether these changes actually prevent cancer is still developing.
Hormone therapy and tamoxifen
Hormone replacement therapy (HRT) used to treat menopause symptoms increases uterine cancer risk if it contains estrogen alone without progesterone. When estrogen is combined with progesterone (called combined HRT), the risk is not increased and may even be lower than in people not taking HRT. This is why doctors now prescribe estrogen-only HRT mainly to people who have had their uterus removed and do not need progesterone protection.
Tamoxifen, a drug used to treat and prevent breast cancer, also increases uterine cancer risk. Tamoxifen acts like estrogen in the uterus even though it blocks estrogen in breast tissue. People taking tamoxifen have about two to three times the risk of developing endometrial cancer. This does not mean people with breast cancer should avoid tamoxifen—the breast cancer benefit usually outweighs the uterine cancer risk—but it is a reason for regular gynecological checkups and prompt reporting of any abnormal bleeding.
The increased risk from tamoxifen typically appears after several years of use and continues even after stopping the drug. Anyone on tamoxifen should know the signs of uterine cancer and report any unusual bleeding to their doctor immediately.
Genetic factors and hereditary syndromes
Most uterine cancers are not inherited, but some families carry genetic mutations that significantly raise the risk. Lynch syndrome (also called hereditary nonpolyposis colorectal cancer or HNPCC) is the most common hereditary cancer syndrome linked to uterine cancer. People with Lynch syndrome have a 40 to 60 percent lifetime risk of developing uterine cancer, often at a younger age than sporadic cases.
Lynch syndrome is caused by mutations in genes that normally repair DNA damage. Without proper repair, mutations accumulate faster in cells throughout the body, including the endometrium. Other hereditary syndromes like Cowden syndrome also increase uterine cancer risk. If you have a strong family history of uterine, colon, or ovarian cancer—especially if cancers occurred before age 50—genetic testing may be worth discussing with your doctor.
Having a family member with uterine cancer does raise your risk somewhat, but most people with a family history will never develop the disease. Genetic counseling can help you understand your actual risk and whether testing makes sense for your situation.
Other factors that increase risk
Several other conditions and exposures raise uterine cancer risk, though usually by a smaller amount than obesity or age. Polycystic ovary syndrome (PCOS) causes irregular periods and higher androgen levels, which can lead to unopposed estrogen stimulation of the endometrium. People with PCOS have a higher risk of endometrial cancer, particularly if they also have obesity or insulin resistance.
Estrogen-producing ovarian tumors, though rare, can cause excessive endometrial stimulation. Atypical endometrial hyperplasia—a precancerous thickening of the uterine lining—is not cancer itself but significantly increases the risk that cancer will develop. A history of breast cancer also modestly increases uterine cancer risk, possibly through shared hormonal or genetic factors.
Race and ethnicity also play a role, though the reasons are complex. Non-Hispanic white women have the highest incidence of uterine cancer in the United States, while Black women have lower incidence but higher mortality rates, likely reflecting differences in access to care and earlier detection rather than biological differences in risk.
Frequently Asked Questions
Can uterine cancer run in families?
Most uterine cancer is not inherited, but Lynch syndrome and other genetic syndromes do run in families and significantly raise risk. If multiple relatives had uterine, colon, or ovarian cancer—especially before age 50—talk to your doctor about whether genetic testing or counseling might help you understand your risk.
Does having irregular periods increase my risk?
Yes. Irregular periods often mean the endometrium is not shedding regularly, so it stays thick longer and is exposed to more estrogen stimulation. Conditions like PCOS that cause irregular periods increase uterine cancer risk. Any change in your menstrual pattern, or bleeding after menopause, should be reported to your doctor.
If I take hormone replacement therapy, will I definitely get uterine cancer?
No. Estrogen-only HRT increases risk, but most people who take it do not develop cancer. The risk is higher the longer you take it and the higher the dose. Combined HRT (estrogen plus progesterone) does not increase risk. Your doctor can help you weigh the benefits and risks based on your personal situation.
Does weight loss lower my risk of uterine cancer?
Weight loss does lower estrogen levels and may reduce risk, but research has not yet proven that losing weight actually prevents uterine cancer. What is clear is that maintaining a healthy weight is linked to lower risk overall, and weight loss has many other health benefits regardless of cancer prevention.
What should I do if I have abnormal bleeding?
Report it to your doctor. Abnormal bleeding is the most common early sign of uterine cancer and is often the reason it is caught at an early, more treatable stage. Do not assume it is normal or wait to see if it goes away on its own, especially if you are past menopause.